Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0152030 (
skin irritation
)
2,146
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Several studies have reported that 1,2-alkanediols show increasing anti-microbial activity as their alkane chain length increases. However, there are no reports on the influence of alkane chain length on the
skin irritation
potential of 1,2-alkanediols. To investigate the influence of alkane chain length on the
skin irritation
potential of 1,2-alkanediols. The objective and subjective (sensory)
skin irritation
potentials of five 1,2-alkanediols -
1,2-butanediol
, 1,2-pentanediol, 1,2-hexanediol, 1,2-octanediol and 1,2-decanediol - were evaluated. We also estimated percutaneous absorption by measuring in vitro skin penetration using a Franz diffusion cell system. Like anti-microbial activity, sensory irritation potential increased as alkane chain length increased, most likely due to increasing membrane interference and/or intrinsic toxicity of 1,2-alkanediols. 1,2-Hexanediol showed the lowest objective
skin irritation
potential, which increased when the alkane chain length decreased or increased. Furthermore, percutaneous absorption negatively correlated with the alkane chain length of 1,2-alkanediols. These results show that a lower skin absorption potential is not indicative of a low
skin irritation
potential. Our results suggest that the factors and processes involved in
skin irritation
potential are complex and that
skin irritation
potential is influenced by intrinsic toxicity and the potential for penetration or integration in the lipid bilayer.
...
PMID:The influence of alkane chain length on the skin irritation potential of 1,2-alkanediols. 2158 1